Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR6 | P46095 | 15/20 | 0.46 |
| ▸ | SCD | O00767 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | PTGFR | P43088 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | IKBKE | Q14164 | 1/20 | 0.36 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13270704 | 0.93 | GPR6 (0.44) | GPR6SCDMAOB | |
| SCHEMBL13634695 | 0.92 | GPR6 (0.43) | GPR6SCDMAOB | |
| SCHEMBL2770451 | 0.88 | GPR6 (0.43) | GPR6SCDHDAC3HDAC2 | |
| SCHEMBL13634609 | 0.88 | GPR6 (0.41) | GPR6SCDHDAC3HDAC2 | |
| SCHEMBL13634849 | 0.88 | GPR6 (0.41) | GPR6SCDHDAC3HDAC2 | |
| SCHEMBL13634679 | 0.87 | IRAK4 (0.43) | GPR6SCD | |
| SCHEMBL13162054 | 0.85 | SCD (0.50) | GPR6SCDHDAC3HDAC2 | |
| SCHEMBL13634621 | 0.85 | GPR6 (0.39) | GPR6SCDPTGFRHDAC3HDAC2 | |
| SCHEMBL2772305 | 0.84 | SCD (0.45) | GPR6SCDPTGFRHDAC3HDAC2 | |
| SCHEMBL13634881 | 0.80 | NPC1 (0.40) | GPR6SCDHDAC3HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304547-B2 | Azolecarboxamide compound or salt thereof | ASTELLAS PHARMA INC. (JP) | 2012-11-06 | — | — | US | disclosed |
| US-8304547-B2 | Azolecarboxamide compound or salt thereof | ASTELLAS PHARMA INC. (JP) | 2012-11-06 | — | — | US | disclosed |